• 1. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Recent Advances in the Study of 6-Chloro-2-(methylamino)pyrimidin-4(3H)-one (CAS: 98025-14-0)

The compound 6-Chloro-2-(methylamino)pyrimidin-4(3H)-one (CAS: 98025-14-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This heterocyclic pyrimidine derivative is recognized for its potential as a key intermediate in the synthesis of biologically active molecules, particularly in the development of kinase inhibitors and antiviral agents. Recent studies have explored its structural properties, synthetic pathways, and therapeutic applications, making it a focal point in drug discovery efforts.

One of the most notable advancements in the study of 6-Chloro-2-(methylamino)pyrimidin-4(3H)-one is its role in the design of selective kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is often associated with cancer and other diseases. Researchers have successfully utilized this compound as a scaffold to develop inhibitors targeting specific kinases, such as cyclin-dependent kinases (CDKs) and mitogen-activated protein kinases (MAPKs). These inhibitors have shown promising results in preclinical studies, demonstrating potent activity and selectivity.

In addition to its applications in kinase inhibition, 6-Chloro-2-(methylamino)pyrimidin-4(3H)-one has been investigated for its antiviral properties. Recent studies have highlighted its potential as a precursor in the synthesis of nucleoside analogs, which are widely used in antiviral therapies. For instance, modifications of this compound have led to the development of novel agents with activity against RNA viruses, including influenza and coronaviruses. These findings underscore the versatility of this pyrimidine derivative in addressing global health challenges.

The synthetic chemistry of 6-Chloro-2-(methylamino)pyrimidin-4(3H)-one has also seen significant progress. Researchers have developed more efficient and scalable methods for its preparation, enabling its broader use in medicinal chemistry. Green chemistry approaches, such as catalytic reactions and solvent-free conditions, have been employed to minimize environmental impact while maintaining high yields and purity. These advancements are critical for the large-scale production of this compound and its derivatives.

Despite these promising developments, challenges remain in the optimization of 6-Chloro-2-(methylamino)pyrimidin-4(3H)-one-based therapeutics. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed to fully realize its clinical potential. Ongoing research is focused on structural modifications and formulation strategies to overcome these limitations. Collaborative efforts between academia and industry are expected to accelerate the translation of these findings into viable drug candidates.

In conclusion, 6-Chloro-2-(methylamino)pyrimidin-4(3H)-one (CAS: 98025-14-0) represents a valuable scaffold in modern drug discovery. Its applications in kinase inhibition and antiviral therapy, coupled with advancements in synthetic methodologies, highlight its importance in chemical biology and pharmaceutical research. Future studies will likely explore its potential in other therapeutic areas, further solidifying its role in the development of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)